U.S. officials have told the EU that they do not expect any distribution of AstraZeneca from the United States in the future. Information provided by the company Reuters, Which refers to two unnamed sources from the EU.
“The United States has told us that AstraZeneca cannot send vaccines to the EU,” a source said, adding that he was directly involved in the EU-US debate.
AstraZeneca has announced that it will provide only half of the benefits agreed to the EU for less than 90 million in the second quarter. However, the company later suggested trying to offset some of the benefits outside the EU, including benefits in the United States. A source told Reuters that the European Commission had already told member state ambassadors not to expect a vaccine from the United States “at this time”. “Any export is tricky in terms of the situation, but there is an option to implement it,” said an unnamed diplomat.
AstraZeneca declined to comment, and the White House withdrew.
It is not clear what is behind vaccination. There is no information on how much AstraZeneca is produced in the United States, but it has not yet been approved for vaccination in the United States.